ArticleClinical trials (London, England)2024
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials.
Pavlos Msaouel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleClinical trials (London, England)2024
Pavlos Msaouel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.